Financial Ratios Huangshan Novel Co.,Ltd
Equities
002014
CNE000001JZ2
Non-Paper Containers & Packaging
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.75 CNY | +0.51% |
|
+0.86% | -1.43% |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.34 | 6.82 | 6.96 | 7.48 | 7.61 | |||||
Return on Total Capital | 9.73 | 9 | 8.92 | 9.23 | 9.19 | |||||
Return On Equity % | 15.73 | 15.28 | 16.4 | 17.15 | 18.33 | |||||
Return on Common Equity | 15.75 | 15.34 | 16.46 | 17.23 | 18.54 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 23.84 | 21.9 | 21.65 | 24.01 | 23.18 | |||||
SG&A Margin | 7.26 | 6.59 | 5.72 | 5.51 | 5.06 | |||||
EBITDA Margin % | 15.8 | 14.76 | 14.9 | 17.67 | 18.49 | |||||
EBITA Margin % | 11.86 | 10.83 | 11.15 | 13.3 | 14.25 | |||||
EBIT Margin % | 11.8 | 10.77 | 11.09 | 13.24 | 14.19 | |||||
Income From Continuing Operations Margin % | 11.28 | 10.62 | 11.16 | 12.26 | 13.37 | |||||
Net Income Margin % | 11.07 | 10.45 | 10.98 | 12.08 | 13.27 | |||||
Net Avail. For Common Margin % | 11.07 | 10.45 | 10.98 | 12.08 | 13.27 | |||||
Normalized Net Income Margin | 7.34 | 6.8 | 6.93 | 8.17 | 9.12 | |||||
Levered Free Cash Flow Margin | 7.77 | -3.13 | 2.12 | 7.83 | 6.75 | |||||
Unlevered Free Cash Flow Margin | 7.92 | -2.96 | 2.37 | 8.17 | 6.96 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1 | 1.01 | 1 | 0.9 | 0.86 | |||||
Fixed Assets Turnover | 3.18 | 3.14 | 2.97 | 2.86 | 3.05 | |||||
Receivables Turnover (Average Receivables) | 4.81 | 4.79 | 4.97 | 4.95 | 4.8 | |||||
Inventory Turnover (Average Inventory) | 8.18 | 8.2 | 7.66 | 7.94 | 8.12 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.18 | 2.32 | 1.93 | 2.02 | 1.94 | |||||
Quick Ratio | 1.87 | 1.87 | 1.59 | 1.75 | 1.66 | |||||
Operating Cash Flow to Current Liabilities | 0.63 | 0.37 | 0.47 | 0.41 | 0.3 | |||||
Days Sales Outstanding (Average Receivables) | 76.05 | 76.13 | 73.4 | 73.73 | 76.21 | |||||
Days Outstanding Inventory (Average Inventory) | 44.73 | 44.49 | 47.67 | 45.94 | 45.09 | |||||
Average Days Payable Outstanding | 75.61 | 68.05 | 67.6 | 66.54 | 61.13 | |||||
Cash Conversion Cycle (Average Days) | 45.16 | 52.57 | 53.47 | 53.13 | 60.17 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 9.6 | 5.61 | 22.21 | 28.43 | 36.14 | |||||
Total Debt / Total Capital | 8.76 | 5.31 | 18.17 | 22.14 | 26.54 | |||||
LT Debt/Equity | - | - | 1.96 | 4.59 | 4.92 | |||||
Long-Term Debt / Total Capital | - | - | 1.61 | 3.58 | 3.61 | |||||
Total Liabilities / Total Assets | 31.24 | 27.85 | 34.93 | 35.83 | 38.89 | |||||
EBIT / Interest Expense | 50.85 | 39.68 | 27.77 | 24.24 | 41.17 | |||||
EBITDA / Interest Expense | 68.06 | 54.38 | 37.31 | 32.36 | 53.65 | |||||
(EBITDA - Capex) / Interest Expense | 26.9 | 25.06 | 13.95 | 26.41 | 41.14 | |||||
Total Debt / EBITDA | 0.45 | 0.27 | 1.05 | 1.19 | 1.46 | |||||
Net Debt / EBITDA | -2.06 | -1.56 | -1.41 | -1.29 | -1.29 | |||||
Total Debt / (EBITDA - Capex) | 1.14 | 0.59 | 2.81 | 1.46 | 1.91 | |||||
Net Debt / (EBITDA - Capex) | -5.21 | -3.38 | -3.78 | -1.58 | -1.68 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 5.3 | 10.45 | 9.27 | 2.26 | 4.34 | |||||
Gross Profit, 1 Yr. Growth % | 6.13 | 1.49 | 8 | 13.42 | 0.74 | |||||
EBITDA, 1 Yr. Growth % | 15.19 | 3.05 | 10.26 | 21.16 | 6.36 | |||||
EBITA, 1 Yr. Growth % | 15.99 | 0.66 | 12.4 | 21.8 | 7.98 | |||||
EBIT, 1 Yr. Growth % | 16.43 | 0.75 | 12.57 | 22.04 | 8.12 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 12.59 | 3.95 | 14.84 | 12.32 | 13.77 | |||||
Net Income, 1 Yr. Growth % | 12.6 | 4.25 | 14.85 | 12.46 | 14.63 | |||||
Normalized Net Income, 1 Yr. Growth % | 15.07 | 2.32 | 11.43 | 20.51 | 12.54 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 9.27 | 5.08 | 15.38 | 11.67 | 13.43 | |||||
Accounts Receivable, 1 Yr. Growth % | -0.95 | 21.25 | -6.24 | 11.68 | 3.62 | |||||
Inventory, 1 Yr. Growth % | -8.8 | 36.86 | 3.29 | -11.88 | 20.38 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 11.03 | 12.53 | 18.1 | -3.5 | -1.24 | |||||
Total Assets, 1 Yr. Growth % | 16.06 | 1.86 | 18.71 | 9.26 | 10.53 | |||||
Tangible Book Value, 1 Yr. Growth % | 6.83 | 7.31 | 7 | 8.18 | 5.63 | |||||
Common Equity, 1 Yr. Growth % | 7.17 | 6.91 | 7.05 | 7.85 | 5.36 | |||||
Cash From Operations, 1 Yr. Growth % | 28.05 | -46 | 83.49 | -5.19 | -10.46 | |||||
Capital Expenditures, 1 Yr. Growth % | 59.94 | -8.02 | 28.19 | -64.43 | 38.58 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 37.84 | -144.43 | -174.16 | 277.39 | -13.26 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 37.31 | -141.25 | -187.63 | 252.38 | -14.1 | |||||
Dividend Per Share, 1 Yr. Growth % | 25.02 | 0 | -4.01 | 37.5 | 12.73 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 8.34 | 7.85 | 9.86 | 5.71 | 3.29 | |||||
Gross Profit, 2 Yr. CAGR % | 13.7 | 3.78 | 4.69 | 10.67 | 6.89 | |||||
EBITDA, 2 Yr. CAGR % | 15.61 | 9.01 | 6.65 | 15.63 | 15.02 | |||||
EBITA, 2 Yr. CAGR % | 17.28 | 8.13 | 6.44 | 17.07 | 16.7 | |||||
EBIT, 2 Yr. CAGR % | 17.43 | 8.31 | 6.5 | 17.21 | 16.84 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 15.75 | 8.18 | 9.26 | 13.58 | 13.04 | |||||
Net Income, 2 Yr. CAGR % | 15.97 | 8.35 | 9.42 | 13.65 | 13.54 | |||||
Normalized Net Income, 2 Yr. CAGR % | 15.65 | 8.5 | 6.78 | 15.88 | 18.48 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 14.51 | 7.16 | 10.47 | 13.51 | 12.55 | |||||
Accounts Receivable, 2 Yr. CAGR % | -0.74 | 9.59 | 6.62 | 2.33 | 7.58 | |||||
Inventory, 2 Yr. CAGR % | -10.82 | 11.72 | 18.9 | -4.6 | 2.99 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 8.4 | 11.78 | 15.28 | 6.75 | -2.38 | |||||
Total Assets, 2 Yr. CAGR % | 7.92 | 8.73 | 9.96 | 13.88 | 9.89 | |||||
Tangible Book Value, 2 Yr. CAGR % | 3.72 | 7.07 | 7.16 | 7.59 | 6.89 | |||||
Common Equity, 2 Yr. CAGR % | 4.07 | 7.04 | 6.98 | 7.45 | 6.6 | |||||
Cash From Operations, 2 Yr. CAGR % | 30.16 | -16.85 | -0.46 | 31.9 | -7.86 | |||||
Capital Expenditures, 2 Yr. CAGR % | 29.76 | 21.29 | 8.58 | -32.47 | -29.79 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 45.37 | -21.74 | -42.6 | 67.29 | 84.2 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 45.58 | -24.74 | -39.87 | 75.73 | 77 | |||||
Dividend Per Share, 2 Yr. CAGR % | 19.52 | 11.81 | -2.02 | 14.89 | 24.5 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 10.88 | 9.04 | 8.32 | 7.27 | 5.25 | |||||
Gross Profit, 3 Yr. CAGR % | 13.24 | 9.48 | 5.17 | 7.52 | 7.26 | |||||
EBITDA, 3 Yr. CAGR % | 11.23 | 11.31 | 9.46 | 11.31 | 13.44 | |||||
EBITA, 3 Yr. CAGR % | 12.83 | 11.51 | 9.58 | 11.37 | 15.29 | |||||
EBIT, 3 Yr. CAGR % | 12.92 | 11.58 | 9.71 | 11.44 | 15.4 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 13.5 | 11.67 | 10.36 | 10.27 | 13.64 | |||||
Net Income, 3 Yr. CAGR % | 13.82 | 11.92 | 10.47 | 10.43 | 13.98 | |||||
Normalized Net Income, 3 Yr. CAGR % | 13.1 | 11.02 | 9.47 | 11.17 | 16.08 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 12.9 | 11.28 | 10.06 | 10.86 | 13.48 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.41 | 6.11 | 4.04 | 8.28 | 2.76 | |||||
Inventory, 3 Yr. CAGR % | -8.05 | 2.87 | 8.84 | 7.6 | 3.09 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 8.98 | 9.76 | 13.85 | 8.64 | 4.02 | |||||
Total Assets, 3 Yr. CAGR % | 7.16 | 5.86 | 11.96 | 9.73 | 12.76 | |||||
Tangible Book Value, 3 Yr. CAGR % | 3.91 | 4.9 | 7.05 | 7.5 | 6.93 | |||||
Common Equity, 3 Yr. CAGR % | 4.11 | 5.01 | 7.04 | 7.27 | 6.75 | |||||
Cash From Operations, 3 Yr. CAGR % | 25.54 | -2.93 | 8.26 | -2.06 | 15.92 | |||||
Capital Expenditures, 3 Yr. CAGR % | 50.67 | 15.7 | 23.55 | -25.15 | -14.19 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 11.73 | -2.08 | -23.13 | 7.54 | 36.01 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 12.24 | -4.38 | -20.82 | 8.4 | 40.02 | |||||
Dividend Per Share, 3 Yr. CAGR % | 18.57 | 12.62 | 6.27 | 9.69 | 14.16 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 8.17 | 9.69 | 10.47 | 7.7 | 6.28 | |||||
Gross Profit, 5 Yr. CAGR % | 10.1 | 8.76 | 9.74 | 9.95 | 5.85 | |||||
EBITDA, 5 Yr. CAGR % | 9.24 | 7.53 | 9.4 | 13.04 | 11.67 | |||||
EBITA, 5 Yr. CAGR % | 10.06 | 8.06 | 10.26 | 13.73 | 12.4 | |||||
EBIT, 5 Yr. CAGR % | 10.13 | 8.1 | 10.31 | 13.8 | 12.51 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 9.78 | 9.12 | 11.78 | 12.43 | 11.43 | |||||
Net Income, 5 Yr. CAGR % | 9.78 | 9.28 | 12.04 | 12.61 | 11.69 | |||||
Normalized Net Income, 5 Yr. CAGR % | 8.96 | 7.84 | 10.53 | 12.94 | 12.99 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 9.2 | 9.16 | 11.92 | 12.31 | 11.05 | |||||
Accounts Receivable, 5 Yr. CAGR % | 3.99 | 5.98 | 2.85 | 4.58 | 5.44 | |||||
Inventory, 5 Yr. CAGR % | 0.41 | 3.58 | 1.91 | -0.19 | 6.46 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 4.09 | 6.5 | 11.46 | 8.55 | 7.06 | |||||
Total Assets, 5 Yr. CAGR % | 6.58 | 5.74 | 8.27 | 9 | 11.13 | |||||
Tangible Book Value, 5 Yr. CAGR % | 3.74 | 4.27 | 5.2 | 5.97 | 6.99 | |||||
Common Equity, 5 Yr. CAGR % | 3.78 | 4.27 | 5.25 | 5.98 | 6.86 | |||||
Cash From Operations, 5 Yr. CAGR % | 16.34 | 1.09 | 14.41 | 9.74 | 1.5 | |||||
Capital Expenditures, 5 Yr. CAGR % | 9.74 | 18.87 | 32.16 | -6.72 | -1.45 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 132.42 | 1.3 | -14.4 | 21.32 | 9.03 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 127.75 | -0.02 | -12.56 | 21.97 | 9.23 | |||||
Dividend Per Share, 5 Yr. CAGR % | 13.4 | 8.45 | 9.86 | 13.52 | 13.22 |
- Stock Market
- Equities
- 002014 Stock
- Financials Huangshan Novel Co.,Ltd
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















